Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 2:20 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 1,407 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Function Clear all

Conditions: Heart Failure, Depression
Interventions: Cognitive Behavior Therapy, Heart Failure Self-care Education; Behavioral · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 30 Years and older
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Coronary Atherosclerosis, Coronary Artery Calcification, Coronary Stenosis
Interventions: Aged garlic extract and Coenzyme Q10; Dietary Supplement
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 35 Years to 84 Years · Male only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Torrance, California

Conditions: Coronary Artery Disease
Interventions: iFR, FFR; Device
Lead sponsor: Imperial College London; Other
Eligibility: 18 Years to 90 Years
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 6
States / cities: Long Beach, California • Lakewood, Colorado • Atlanta, Georgia + 3 more

Conditions: HIV Infection, Cardiovascular Disease, Inflammation, HIV Infections
Interventions: Maraviroc, placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Ischemic Stroke
Interventions: tDCS, Sham tDCS; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cardiomyopathy, Heart Failure
Interventions: Laboratory Biomarker Analysis, Standard of Care, Mesenchymal Stem Cell Transplantation; Other · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Metabolic Acidosis, Kidney Transplant; Complications, Vascular Diseases
Interventions: Sodium bicarbonate, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hypertension, Diastolic Dysfunction
Interventions: valsartan, amlodipine; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 45 Years and older
Enrollment: 229 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: USA, New Jersey

Conditions: Multiple Myeloma, Advanced Solid Tumors
Interventions: Ixazomib; Drug
Lead sponsor: Millennium Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 10
States / cities: Atlanta, Georgia • Peoria, Illinois • Fairway, Kansas + 7 more

Conditions: Cerebrovascular Accident
Interventions: Control, Experimental; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mantle Cell Lymphoma
Interventions: Leuprolide acetate depot (LAD) 11.25 mg 3 Month, Matched placebo; Drug
Lead sponsor: Abbott; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 4
States / cities: St Louis, Missouri • New York, New York • Durham, North Carolina + 1 more

Conditions: Type 1 Diabetes (Juvenile Onset), Type 1 Diabetes, Diabetes, Autoimmune
Interventions: Not listed
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 70 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Obesity, Insulin Resistance, Cardiovascular Risk Factor
Interventions: Exercise; Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Metabolic Syndrome, Hypertension
Interventions: 14 Nitrogen (N) Sodium Nitrite, Placebo; Drug
Lead sponsor: Gladwin, Mark, MD; Individual
Eligibility: 18 Years to 60 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Perimenopause, Vasodilation, Estrogen
Interventions: Estradiol (mylan or vivelle dot patch), Placebo; Drug · Other
Lead sponsor: University of Delaware; Other
Eligibility: 40 Years to 58 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Microbiome, Immune Function, Cardiovascular Diseases
Interventions: Meat products, Plant Alternative products; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Stroke
Interventions: SaeboFlex Dynamic Hand Orthosis, Saebo F.T.M. Arm Training Program; Device · Procedure
Lead sponsor: Kessler Foundation; Other
Eligibility: Not listed
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 3
States / cities: Chester, New Jersey • East Orange, New Jersey • Saddle Brook, New Jersey

Conditions: Stroke
Interventions: Not listed
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Deafness, Kidney Diseases, Kidney Neoplasms, Neoplasms, Retinal Diseases
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mitral Valve Regurgitation (Degenerative or Functional)
Interventions: INNOVALVE system; Device
Lead sponsor: Edwards Lifesciences; Industry
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2034
U.S. locations: 21
States / cities: Los Angeles, California • Palo Alto, California • Naples, Florida + 15 more

Conditions: Stroke
Interventions: Noninvasive spinal stimulation with gait training, Conventional gait training; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stroke
Interventions: Neural feedback plus FES and motor training; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 88 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Breast Cancer, Breast Neoplasm Female
Interventions: High-Intensity Interval Training, Moderate-Intensity Exercise; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older · Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease, Acute Myeloid Leukemia, Myeloproliferative Disorders
Interventions: Leuprolide, hematopoietic cell transplant, reduced intensity allogeneic HCT; Drug · Biological
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 50 Years and older · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Depression and Self-care in Heart Failure

Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)

Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation

Effect of Maraviroc on Endothelial Function in HIV-Infected Patients

Transcranial Direct Current Stimulation (tDCS)-Enhanced Stroke Recovery

Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines

Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients

The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction

Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment

Mechanisms of Upper-Extremity Motor Recovery in Post-stroke Hemiparesis

A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

Type 1 Diabetes Autonomic and Vascular Function

Effects of Obesity and Intensity of Exercise on Ghrelin Levels

Oral Nitrite Trial for Hypertension and Metabolic Syndrome

Impact of Estradiol on Endothelial Function in Peri-Menopausal Women

SWAP-MEAT: Study With Appetizing Plant Food - Meat Eating Alternatives Trial

Saeboflex Dynamic Hand Orthosis for Inpatient Rehabilitation Stroke Patients

Evaluation of Sensorimotor Ankle Impairments in Chronic Stroke

Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors

TVMR With the INNOVALVE System Trial - Early Feasibility Study

Noninvasive Spinal Stimulation in Stroke

Novel Brain Signal Feedback Paradigm to Enhance Motor Learning After Stroke

High-intensity Exercise After Treatment

Preservation of Ovarian Function After Hematopoietic Cell Transplant